Sensei Biotherapeutics SNSE Stock
Sensei Biotherapeutics Price Chart
Sensei Biotherapeutics SNSE Financial and Trading Overview
| Sensei Biotherapeutics stock price | 1.05 USD |
| Previous Close | 1.34 USD |
| Open | 1.34 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 1.33 - 1.35 USD |
| 52 Week Range | 1.28 - 2.39 USD |
| Volume | 7.98K USD |
| Avg. Volume | 74.76K USD |
| Market Cap | 41.51M USD |
| Beta (5Y Monthly) | -0.194236 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.33 USD |
SNSE Valuation Measures
| Enterprise Value | -46239672 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.9054054 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.43747962 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1 |
Trading Information
Sensei Biotherapeutics Stock Price History
| Beta (5Y Monthly) | -0.194236 |
| 52-Week Change | -29.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.39 USD |
| 52 Week Low | 1.28 USD |
| 50-Day Moving Average | 1.49 USD |
| 200-Day Moving Average | 1.52 USD |
SNSE Share Statistics
| Avg. Volume (3 month) | 74.76K USD |
| Avg. Daily Volume (10-Days) | 27.74K USD |
| Shares Outstanding | 30.98M |
| Float | 20.91M |
| Short Ratio | 6.9 |
| % Held by Insiders | 32.86% |
| % Held by Institutions | 23.18% |
| Shares Short | 150.3K |
| Short % of Float | 0.89% |
| Short % of Shares Outstanding | 0.48% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.068% |
| Return on Equity (ttm) | -40.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -46238000 USD |
| Net Income Avi to Common (ttm) | -46360000 USD |
| Diluted EPS (ttm) | -1.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 95.51M USD |
| Total Cash Per Share (mrq) | 3.08 USD |
| Total Debt (mrq) | 7.75M USD |
| Total Debt/Equity (mrq) | 8.17 USD |
| Current Ratio (mrq) | 13.004 |
| Book Value Per Share (mrq) | 3.063 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -40012000 USD |
| Levered Free Cash Flow (ttm) | -24050876 USD |
Profile of Sensei Biotherapeutics
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 1405 Research Boulevard |
| ZIP | 20850 |
| Phone | 240 243 8000 |
| Website | https://www.senseibio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 27 |
Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Q&A For Sensei Biotherapeutics Stock
What is a current SNSE stock price?
Sensei Biotherapeutics SNSE stock price today per share is 1.05 USD.
How to purchase Sensei Biotherapeutics stock?
You can buy SNSE shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sensei Biotherapeutics?
The stock symbol or ticker of Sensei Biotherapeutics is SNSE.
Which industry does the Sensei Biotherapeutics company belong to?
The Sensei Biotherapeutics industry is Biotechnology.
How many shares does Sensei Biotherapeutics have in circulation?
The max supply of Sensei Biotherapeutics shares is 25.07M.
What is Sensei Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Sensei Biotherapeutics PE Ratio is now.
What was Sensei Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Sensei Biotherapeutics EPS is -1.22 USD over the trailing 12 months.
Which sector does the Sensei Biotherapeutics company belong to?
The Sensei Biotherapeutics sector is Healthcare.
Sensei Biotherapeutics SNSE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}